What is the recommended treatment (tx) for gonorrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Gonorrhea

The recommended treatment for gonorrhea is a single intramuscular dose of ceftriaxone 500 mg plus doxycycline 100 mg orally twice daily for 7 days if chlamydial infection has not been ruled out. 1, 2, 3

First-Line Treatment Regimen

  • Ceftriaxone 500 mg IM as a single dose 1, 2

    • This is the most effective injectable antibiotic for gonorrhea treatment 4
    • Provides high and sustained bactericidal levels in the blood
    • Effective at all anatomic sites of infection (urogenital, anorectal, and pharyngeal)
  • Plus (if chlamydial infection not excluded):

    • Doxycycline 100 mg orally twice daily for 7 days 1, 2

Anatomical Site Considerations

  • Pharyngeal gonorrhea:

    • More difficult to eradicate than urogenital or anorectal infections 5, 1
    • Test-of-cure recommended 7-14 days after treatment 1
    • Ceftriaxone is highly effective for pharyngeal infections 5
  • Urogenital and anorectal infections:

    • No test-of-cure needed if treated with recommended regimen 1
    • High cure rates with ceftriaxone 5

Evolution of Treatment Recommendations

Treatment guidelines have evolved due to increasing antimicrobial resistance:

  • Previous recommendations included cefixime 400 mg orally, but this is no longer recommended as first-line therapy due to decreased effectiveness and treatment failures 5, 6
  • Azithromycin (previously recommended as part of dual therapy) is no longer recommended due to rapidly increasing resistance 2, 3
  • Single-dose azithromycin 2g has been shown to be effective but causes significant gastrointestinal side effects and is expensive 7

Partner Management

  • All sexual partners from the previous 60 days should be evaluated and treated 5, 1
  • If a patient's last sexual contact was >60 days before diagnosis, the most recent partner should be treated 5
  • Patients should avoid sexual intercourse until therapy is completed and both they and their partners no longer have symptoms 5

Alternative Regimens for Patients with Cephalosporin Allergy

  • Gentamicin 240 mg IM plus azithromycin 2 g orally 1, 4
  • Spectinomycin 2 g IM (if available) 5
    • Useful for patients who cannot tolerate cephalosporins
    • Less effective for pharyngeal infections

Follow-Up

  • Retesting is recommended for all patients 3 months after treatment due to high reinfection rates 1
  • Test-of-cure is not needed for uncomplicated urogenital or rectal gonorrhea treated with recommended regimens 1
  • Test-of-cure is recommended for pharyngeal infections 7-14 days after treatment 1

Treatment Failures

For patients with persistent infection after treatment with the recommended regimen:

  • Culture relevant clinical specimens
  • Perform antimicrobial susceptibility testing of N. gonorrhoeae isolates 5
  • Consider alternative treatment regimens based on susceptibility results

Common Pitfalls to Avoid

  • Underdosing ceftriaxone (now 500 mg, not the previously recommended 250 mg)
  • Using oral cephalosporins for pharyngeal infections
  • Inadequate partner treatment
  • Using azithromycin alone due to high resistance rates
  • Failing to test for other STIs, particularly chlamydia

The shift to higher-dose ceftriaxone monotherapy (with doxycycline added for possible chlamydial co-infection) reflects the need to preserve antibiotic effectiveness and practice antimicrobial stewardship while ensuring high cure rates for all anatomical sites of infection.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.